CORD-19:c654596857bce9cdd64ffc51842048643107348c / 375699-375827 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/c654596857bce9cdd64ffc51842048643107348c","sourcedb":"CORD-19","sourceid":"c654596857bce9cdd64ffc51842048643107348c","text":"Potentially treatment-related adverse events occurred in 7.7% of the brivudin recipients and in 10% of the acyclovir recipients.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T3222","span":{"begin":0,"end":128},"obj":"Sentence"},{"id":"T86333","span":{"begin":0,"end":128},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T3222","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T86333","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"Epistemic_Statements","denotations":[{"id":"T484","span":{"begin":0,"end":128},"obj":"Epistemic_statement"}],"attributes":[{"subj":"T484","pred":"source","obj":"Epistemic_Statements"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T222","span":{"begin":0,"end":128},"obj":"Sentence"}],"attributes":[{"subj":"T222","pred":"source","obj":"CORD-19_Custom_license_subset"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ec93e7","default":true},{"id":"Epistemic_Statements","color":"#93ecd6"},{"id":"CORD-19_Custom_license_subset","color":"#ecbc93"}]}]}}